Richard Maziarz: Where We Are and Where Cell Therapy Is Going?
Richard Maziarz, Medical Director, Blood and Marrow Transplant, Cellular Therapy Program at Oregon Health and Science University, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Transplantation and Cellular Therapy, adding:
”Where we are, where we are going?
That was the message delivered during the opening session at the Tandem meetings 2026: A summary of the CIBMTR/EBMT/ASTCT collaborative has just been published.
The work ahead is daunting but the future looks bright for cell therapy clinical care delivery.”
Title: Challenges with expansion of cell and gene therapy: A call for system-level action
Authors: Jeffery J. Auletta, Alvaro Urbano-Ispizua, Richard T. Maziarz, Anna Sureda, Sumithra Vasu, David L. Porter

Stay updated wih Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series